Pancreatic Carcinoma — Trials

Pancreatic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 489
Recruiting: 282
Ph III recruiting: 29
Growth YoY: +27.7%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04575363	RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer(PaCaBioMarkeR)	recruiting	N/A	90	CHU de ReimsOTHER	1	Nov 9, 2023	clinicaltrials
NCT06065891	Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer(PALN)	recruiting	N/A	300	Jon UnossonOTHER	2	Oct 4, 2023	clinicaltrials